Literature DB >> 32686940

Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Shikha Kumari1, Angelica V Carmona1, Amit K Tiwari2, Paul C Trippier1,3,4.   

Abstract

The amide functional group plays a key role in the composition of biomolecules, including many clinically approved drugs. Bioisosterism is widely employed in the rational modification of lead compounds, being used to increase potency, enhance selectivity, improve pharmacokinetic properties, eliminate toxicity, and acquire novel chemical space to secure intellectual property. The introduction of a bioisostere leads to structural changes in molecular size, shape, electronic distribution, polarity, pKa, dipole or polarizability, which can be either favorable or detrimental to biological activity. This approach has opened up new avenues in drug design and development resulting in more efficient drug candidates introduced onto the market as well as in the clinical pipeline. Herein, we review the strategic decisions in selecting an amide bioisostere (the why), synthetic routes to each (the how), and success stories of each bioisostere (the implementation) to provide a comprehensive overview of this important toolbox for medicinal chemists.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32686940      PMCID: PMC7666045          DOI: 10.1021/acs.jmedchem.0c00530

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  288 in total

1.  Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias.

Authors:  M Koufaki; T Calogeropoulou; A Detsi; A Roditis; A P Kourounakis; P Papazafiri; K Tsiakitzis; C Gaitanaki; I Beis; P N Kourounakis
Journal:  J Med Chem       Date:  2001-11-22       Impact factor: 7.446

2.  Synthesis and cytotoxicity of new 3-alkyl-1-(1-methyl-2-phenylethyl)ureas related to ceramide.

Authors:  Sejin Lim; Jae Hark Ryu; Chaeuk Im; Chul Bu Yim
Journal:  Arch Pharm Res       Date:  2003-04       Impact factor: 4.946

3.  Oxetanes as promising modules in drug discovery.

Authors:  Georg Wuitschik; Mark Rogers-Evans; Klaus Müller; Holger Fischer; Björn Wagner; Franz Schuler; Liudmila Polonchuk; Erick M Carreira
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-27       Impact factor: 15.336

4.  Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.

Authors:  Chandra Bhushan Mishra; Apra Manral; Shikha Kumari; Vikas Saini; Manisha Tiwari
Journal:  Bioorg Med Chem       Date:  2016-06-14       Impact factor: 3.641

5.  Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity.

Authors:  Jean-Pierre Falgueyret; Sylvie Desmarais; Renata Oballa; W Cameron Black; Wanda Cromlish; Karine Khougaz; Sonia Lamontagne; Frederic Massé; Denis Riendeau; Sylvie Toulmond; M David Percival
Journal:  J Med Chem       Date:  2005-12-01       Impact factor: 7.446

6.  Comparative trial of diazepam and pheneturide in treatment of epilepsy.

Authors:  H I Hershon; M Parsonage
Journal:  Lancet       Date:  1969-10-25       Impact factor: 79.321

7.  Synthesis and cytotoxicity of new aromatic ceramide analogs with alkylsulfonamido chains.

Authors:  Kyoungwon Kim; Joosung Kang; Seungyong Kim; Suhang Choi; Sejin Lim; Chaeuk Im; Chulbu Yim
Journal:  Arch Pharm Res       Date:  2007-05       Impact factor: 4.946

8.  Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs.

Authors:  Michael C Byrns; Trevor M Penning
Journal:  Chem Biol Interact       Date:  2008-11-01       Impact factor: 5.192

Review 9.  Pharmacology of imatinib (STI571).

Authors:  Elisabeth Buchdunger; Terence O'Reilly; Jeanette Wood
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

Review 10.  Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.

Authors:  Magdalena Slusarczyk; Michaela Serpi; Fabrizio Pertusati
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec
View more
  34 in total

1.  Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket.

Authors:  Matthew G Lloyd; Rosemary Huckvale; Kwai-Ming J Cheung; Matthew J Rodrigues; Gavin W Collie; Olivier A Pierrat; Mahad Gatti Iou; Michael Carter; Owen A Davis; P Craig McAndrew; Emma Gunnell; Yann-Vaï Le Bihan; Rachel Talbot; Alan T Henley; Louise D Johnson; Angela Hayes; Michael D Bright; Florence I Raynaud; Mirco Meniconi; Rosemary Burke; Rob L M van Montfort; Olivia W Rossanese; Benjamin R Bellenie; Swen Hoelder
Journal:  J Med Chem       Date:  2021-11-30       Impact factor: 7.446

2.  Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability.

Authors:  Md Shafikur Rahman; Shikha Kumari; Shiva Hadi Esfahani; Saeideh Nozohouri; Srinidhi Jayaraman; Nihar Kinarivala; Joanna Kocot; Andrew Baez; Delaney Farris; Thomas J Abbruscato; Vardan T Karamyan; Paul C Trippier
Journal:  J Med Chem       Date:  2021-08-26       Impact factor: 8.039

3.  Bioisostere Effects on the EPSA of Common Permeability-Limiting Groups.

Authors:  Andrew K Ecker; Dorothy A Levorse; Daniel A Victor; Matthew J Mitcheltree
Journal:  ACS Med Chem Lett       Date:  2022-05-23       Impact factor: 4.632

4.  Synthesis and Evaluation of Small Molecule Disruptors of the Aha1/Hsp90 Complex for the Reduction of Tau Aggregation.

Authors:  Bradley M Keegan; Kevin C Catalfano; Monimoy Banerjee; Brian S J Blagg
Journal:  ACS Med Chem Lett       Date:  2022-04-15       Impact factor: 4.632

5.  Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain.

Authors:  Santo Previti; Roberta Ettari; Elsa Calcaterra; Carla Di Chio; Rahul Ravichandran; Collin Zimmer; Stefan Hammerschmidt; Annika Wagner; Marta Bogacz; Sandro Cosconati; Tanja Schirmeister; Maria Zappalà
Journal:  ACS Med Chem Lett       Date:  2022-06-30       Impact factor: 4.632

6.  Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy.

Authors:  Liping Zhang; Emily C Cherney; Xiao Zhu; Tai-An Lin; Johnni Gullo-Brown; Derrick Maley; Kathy Johnston-Allegretto; Lisa Kopcho; Mark Fereshteh; Christine Huang; Xin Li; Sarah C Traeger; Gopal Dhar; Aravind Anandam; Sandeep Mahankali; Shweta Padmanabhan; Prabhakar Rajanna; Venkata Murali; Thanga Mariappan; Robert Borzilleri; Gregory Vite; John T Hunt; Aaron Balog
Journal:  ACS Med Chem Lett       Date:  2021-03-02       Impact factor: 4.345

7.  1,5-Disubstituted 1,2,3-Triazoles as Amide Bond Isosteres Yield Novel Tumor-Targeting Minigastrin Analogs.

Authors:  Nathalie M Grob; Roger Schibli; Martin Béhé; Ibai E Valverde; Thomas L Mindt
Journal:  ACS Med Chem Lett       Date:  2021-03-16       Impact factor: 4.345

8.  Structure property relationships of N-acylsulfonamides and related bioisosteres.

Authors:  Karol R Francisco; Carmine Varricchio; Thomas J Paniak; Marisa C Kozlowski; Andrea Brancale; Carlo Ballatore
Journal:  Eur J Med Chem       Date:  2021-03-28       Impact factor: 7.088

9.  New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators.

Authors:  Serena Montanari; Marco Allarà; Laura Scalvini; Magdalena Kostrzewa; Federica Belluti; Silvia Gobbi; Marina Naldi; Silvia Rivara; Manuela Bartolini; Alessia Ligresti; Alessandra Bisi; Angela Rampa
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

10.  Development of Non-Ethoxypropanoic Acid Type Cryptochrome Inhibitors with Circadian Molecular Clock-Enhancing Activity by Bioisosteric Replacement.

Authors:  Yong Uk Jeong; Hyo-Eon Jin; Hye Young Lim; Goyeong Choi; Hansol Joo; Bohun Kang; Ga-Hyun Lee; Kwang-Hyeon Liu; Han-Joo Maeng; Sooyoung Chung; Gi Hoon Son; Jong-Wha Jung
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.